Experts Debate Aspirin for Primary Prevention in Type 2 Diabetes Experts Debate Aspirin for Primary Prevention in Type 2 Diabetes
At IDF 2021, two speakers presented different views on the benefit-risk balance of cardiovascular protection versus bleeding risk in those who haven ' t already had a vascular event.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 10, 2021 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news
Older Anticoagulants Linked to Brain Hemorrhage After Trauma Older Anticoagulants Linked to Brain Hemorrhage After Trauma
Consider repeat head CT scans for trauma patients who are taking any anticoagulants or antiplatelet medications concurrently with aspirin, researchers say.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - December 3, 2021 Category: Emergency Medicine Tags: Radiology News Source Type: news
Can Aspirin Prolong Survival in Patients With NSCLC? Can Aspirin Prolong Survival in Patients With NSCLC?
A new study shows that people with inoperable non-small cell lung cancer who took the cheap painkiller survived longer, but questions linger.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 1, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Daily Aspirin Linked to Increased Risk of Heart Failure Daily Aspirin Linked to Increased Risk of Heart Failure
New data from a follow-up of more than 30,000 participants without heart failure at enrollment suggests that daily use of aspirin is associated with new onset heart failure.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 24, 2021 Category: Cardiology Tags: Cardiology News Source Type: news
Coffee, Smoking and Aspirin Influence Parkinson's Disease Onset Coffee, Smoking and Aspirin Influence Parkinson's Disease Onset
Coffee drinking, aspirin use, and smoking influence the age of onset and the extent of clinical symptoms in patients with Parkinson ' s disease, early research suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - November 24, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Aspirin is linked with increased risk of heart failure
Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor for the condition. That’s the finding of a study published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC). Predisposing factors included smoking, obesity, high blood pressure, high cholesterol, diabetes, and cardiovascular disease. (Source: World Pharma News)
Source: World Pharma News - November 23, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial, The Lancet
Study (n=14 892 [66%] of 22,560 in RECOVERY trial) found aspirin was not linked to reductions in 28 day mortality or in risk of progressing to invasive mechanical ventilation or death, but was associated with a small increase in rate of being discharged alive within 28 days. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 19, 2021 Category: Consumer Health News Source Type: news
Low-Dose Aspirin Won't Affect Dementia Risk in People With Diabetes
Title: Low-Dose Aspirin Won ' t Affect Dementia Risk in People With DiabetesCategory: Health NewsCreated: 11/19/2021 12:00:00 AMLast Editorial Review: 11/19/2021 12:00:00 AM (Source: MedicineNet Alzheimer)
Source: MedicineNet Alzheimer - November 19, 2021 Category: Geriatrics Source Type: news
Who Should, and Who Shouldn't, Take Aspirin for Primary Prevention Who Should, and Who Shouldn't, Take Aspirin for Primary Prevention
Dr Kenny Lin shares his decision-making on the use of aspirin for primary prevention.Georgetown University Family Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 18, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Commentary Source Type: news
ASCEND: Hint of Dementia Protection With Aspirin in T2D ASCEND: Hint of Dementia Protection With Aspirin in T2D
Daily low-dose aspirin failed to produce significant reduction of dementia or cognitive impairment in a randomized trial, but there was a hint of benefit that warrants further study, experts say.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 17, 2021 Category: Cardiology Tags: Cardiology News Source Type: news
Why aspirin guidelines are changing when it comes to preventing heart disease
New recommendations of an aspirin a day to prevent heart attack and stroke are in progress. Although the U.S. Preventive Services Task Force has not issued a final recommendation on the use of aspirin in cardiovascular disease prevention, it's a good time for you to talk with your health care provider. "Evidence is pointing to the fact that we're not seeing a benefit from using low-dose aspirin for reducing risk in patients who don't already… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 16, 2021 Category: Databases & Libraries Source Type: news
Janssen to Present the Strength and Promise of its Hematologic Malignancies Portfolio and Pipeline at ASH 2021
RARITAN, N.J., November 4, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 45 company-sponsored abstracts, including 11 oral presentations, plus more than 35 investigator-initiated studies will be featured at the American Society of Hematology (ASH) Annual Meeting and Exposition. ASH is taking place at the Georgia World Congress Center in Atlanta and virtually from December 11-14, 2021.“We are committed to advancing the science and treatment of hematologic malignancies and look forward to presenting the latest research from our robust portfolio and pipeline during ASH...
Source: Johnson and Johnson - November 5, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Time to rethink daily doses of aspirin if you don’t have heart disease, experts say
The pain reliever can be a lifesaver, helping to reduce the likelihood of heart attack or stroke for some. But regular use may cause serious side effects, notably internal bleeding. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - November 1, 2021 Category: Consumer Health News Authors: Lindsey Konkel Source Type: news
Study: Apps could improve communication between providers, pregnant patients
The study found only 46% of patients eligible for prophylactic low-dose aspirin due to high-risk factors for preeclampsia had gotten a provider recommendation by 16 weeks gestation. (Source: mobihealthnews)
Source: mobihealthnews - November 1, 2021 Category: Information Technology Source Type: news
Multifetal Gestations and Associated Perinatal Risks
Along with the rise of assisted reproductive technology, multifetal gestations increased dramatically. Twin pregnancies account for 97% of multifetal pregnancies and 3% of all births in the United States. Twins and higher-order multiples carry increased risks of obstetric, perinatal, and maternal complications; these risks increase with increasing fetal number. Neonatal morbidity and mortality in multifetal gestations is driven primarily by prematurity. Both spontaneous and indicated preterm births are increased in multifetal gestations, and only a limited number of strategies are available to mitigate this risk. No single...
Source: NeoReviews recent issues - November 1, 2021 Category: Pediatrics Source Type: news
